ATE532777T1 - Substituierte chromanderivate, medikamente und anwendungen in der therapie - Google Patents

Substituierte chromanderivate, medikamente und anwendungen in der therapie

Info

Publication number
ATE532777T1
ATE532777T1 AT05779877T AT05779877T ATE532777T1 AT E532777 T1 ATE532777 T1 AT E532777T1 AT 05779877 T AT05779877 T AT 05779877T AT 05779877 T AT05779877 T AT 05779877T AT E532777 T1 ATE532777 T1 AT E532777T1
Authority
AT
Austria
Prior art keywords
derivatives
chromeder
medications
therapy
substituted
Prior art date
Application number
AT05779877T
Other languages
English (en)
Inventor
Andrew Heaton
Alan James Husband
Original Assignee
Marshall Edwards Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU2004/001619 external-priority patent/WO2005049008A1/en
Priority claimed from AU2005201855A external-priority patent/AU2005201855B2/en
Application filed by Marshall Edwards Inc filed Critical Marshall Edwards Inc
Application granted granted Critical
Publication of ATE532777T1 publication Critical patent/ATE532777T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/38—2,3-Dihydro derivatives, e.g. isoflavanones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05779877T 2004-09-21 2005-09-21 Substituierte chromanderivate, medikamente und anwendungen in der therapie ATE532777T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61130004P 2004-09-21 2004-09-21
PCT/AU2004/001619 WO2005049008A1 (en) 2003-11-19 2004-11-19 Combinational radiotherapy and chemotherapy compositions and methods
AU2005201855A AU2005201855B2 (en) 2004-09-21 2005-05-03 Chroman derived compounds and formulations thereof for use in therapy
PCT/AU2005/001435 WO2006032085A1 (en) 2004-09-21 2005-09-21 Substituted chroman derivatives, medicaments and use in therapy

Publications (1)

Publication Number Publication Date
ATE532777T1 true ATE532777T1 (de) 2011-11-15

Family

ID=36089770

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05779877T ATE532777T1 (de) 2004-09-21 2005-09-21 Substituierte chromanderivate, medikamente und anwendungen in der therapie

Country Status (11)

Country Link
US (6) US7601855B2 (de)
EP (2) EP1794141B1 (de)
CN (1) CN101056868B (de)
AT (1) ATE532777T1 (de)
AU (1) AU2005287865B2 (de)
CA (1) CA2581316C (de)
IL (1) IL182034A (de)
MX (1) MX2007003216A (de)
NO (1) NO20072004L (de)
NZ (1) NZ553834A (de)
WO (1) WO2006032085A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005287865B2 (en) 2004-09-21 2012-02-16 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
JP2008537545A (ja) * 2005-03-24 2008-09-18 ノボジェン リサーチ ピーティーワイ リミテッド イソフラボノイド二量体
EP2120925A4 (de) * 2007-03-16 2010-04-07 Novogen Res Pty Ltd Verfahren zur einleitung von autophagie
WO2010022467A1 (en) * 2008-08-29 2010-03-04 Novogen Research Pty Ltd Immunomodulating activities
WO2012061413A2 (en) * 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compositions and methods for the treatment of cancer
US20120251630A1 (en) * 2011-03-29 2012-10-04 Marshall Edwards, Inc. Remission therapy of cancer with isoflavonoids
US8911935B2 (en) 2011-10-17 2014-12-16 New York University Mitochondria and human immunodefiency virus type 1
KR101459195B1 (ko) 2012-12-28 2014-11-07 경기대학교 산학협력단 항암 활성을 갖는 4-니트로알킬크로만 유도체, 이의 제조방법 및 이를 포함하는 약학 조성물
BR112016018099B8 (pt) 2014-02-07 2023-01-17 Novogen ltd Compostos funcionalizados de benzopiranos e uso dos mesmos
AU2016215515B2 (en) 2015-02-02 2020-04-30 Mei Pharma, Inc. Combination therapies
EP3439642A4 (de) * 2016-04-06 2019-11-13 Noxopharm Limited Verbesserungen an der strahlentherapie
EP3439644B1 (de) 2016-04-06 2022-01-12 Noxopharm Limited Isoflavonoidzusammensetzung mit verbesserter pharmakokinetik
AU2021247415A1 (en) 2020-03-30 2022-09-29 Noxopharm Limited Methods for the treatment of inflammation associated with infection
WO2023090829A1 (ko) * 2021-11-17 2023-05-25 엘젠테라퓨틱스 주식회사 Mll1-wdr5 상호작용을 조절하는 저분자 화합물 및 이의 용도
WO2024232597A1 (ko) * 2023-05-10 2024-11-14 엘젠테라퓨틱스 주식회사 Wdr5를 분해하는 4-크로만온 화합물 및 이의 용도
CN118005595B (zh) * 2023-05-24 2024-10-29 内蒙古大学 具有烯丙醇结构色满衍生物的合成及抗肿瘤活性

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
DE1518002C3 (de) 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1543749A1 (de) 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
GB1433013A (de) 1973-06-08 1976-04-22
US4157984A (en) 1977-06-08 1979-06-12 Z-L Limited Antioxidants, antioxidant compositions and methods of preparing and using same
US4218489A (en) 1977-06-08 1980-08-19 Z-L Limited Partnership Antioxidants, antioxidant compositions and methods of preparing and using same
US4264509A (en) 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4232122A (en) 1979-01-17 1980-11-04 Z-L Limited Partnership Antioxidants, antioxidant compositions and methods of preparing and using same
US4234577A (en) 1979-03-19 1980-11-18 Z-L Limited Partnership Ergostadientriols, compositions containing same, and methods of preparing and using same
US4368264A (en) 1979-03-19 1983-01-11 Z-L Limited Partnership Fermentation methods of preparing ergostadientriols
US4366082A (en) 1979-04-11 1982-12-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4390559A (en) 1979-04-11 1983-06-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4366248A (en) 1979-04-11 1982-12-28 Z-L Limited Partnership Fermentation method of preparing antioxidants
US4447622A (en) 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US4644012A (en) 1983-12-21 1987-02-17 Takeda Chemical Industries, Ltd. Treatment for osteoporosis
GB8626344D0 (en) 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
MX13485A (es) 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
US5059609A (en) 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
DE69023906T2 (de) 1990-08-09 1996-04-11 Council Scient Ind Res Benzopyrane und Verfahren zu deren Herstellung.
WO1994008986A1 (en) 1992-10-21 1994-04-28 Pfizer, Inc. Enantiomeric cis-3-(4,6-dihydroxychroman-3-yl-methyl)benzoic acids
US5451603A (en) 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5280040A (en) 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5389646A (en) 1993-12-30 1995-02-14 Zymogenetics, Inc. Methods for treatment and prevention of bone loss using 2,3-benzopyrans
US5792776A (en) 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
CZ212497A3 (en) 1995-01-13 1997-11-12 Novo Nordisk As Use of 3,4-diphenylchromans for preparing pharmaceutical preparations for treating or prophylaxis of idiopathic or physiological gynecomastia
EP0804189A1 (de) 1995-01-13 1997-11-05 Novo Nordisk A/S Verwendung von 3,4-diphenylchromanen zur herstellung eines arzneimittels zur behandlung bzw. prophylaxe der hyperlipoproteinämie, hypertriglyceridämie, hyperlipidämie oder der hypercholesterinämie oder der arteriosklerose oder für eine antikoagulative behandlung
HUP9702244A3 (en) 1995-01-13 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
HUP9800297A3 (en) 1995-01-20 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for the manufacture of a vasodilatory pharmaceutical composition
BR9606766A (pt) 1995-01-20 1997-12-30 Novo Nordisk As Utilização de compostos e processo para o tratamento e profilaxia de disturbios degenerativos cerebrais
TW448046B (en) 1995-01-20 2001-08-01 Novo Nordisk As Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
US5849461A (en) 1995-08-01 1998-12-15 Shin-Etsu Chemical Co., Ltd. Chemically amplified positive resist composition
US5747059A (en) 1996-01-11 1998-05-05 Novo Nordisk A/S Atrophy of skin/mucous membrane
US5726202A (en) 1996-01-11 1998-03-10 Novo Nordisk A/S Benign prostatic hypertrophy
CZ217298A3 (cs) 1996-01-11 1999-01-13 Novo Nordisk A/S Použití 3,4-difenyl chromanů pro výrobu farm. prostředku
US5883118A (en) 1996-01-11 1999-03-16 Nova Nordisk A/S Prostatic carcinoma
US5756539A (en) 1996-07-11 1998-05-26 Novo Nordis A/S 3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders
AU3433997A (en) 1996-07-12 1998-02-09 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure
US5780502A (en) * 1996-07-12 1998-07-14 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
WO1998002154A1 (en) 1996-07-12 1998-01-22 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
AUPO203996A0 (en) 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
GB9621757D0 (en) 1996-10-18 1996-12-11 Ciba Geigy Ag Phenyl-substituted bicyclic heterocyclyl derivatives and their use
US5919817A (en) * 1996-10-28 1999-07-06 Novo Nordisk A/S Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979644B (en) 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
US6316494B1 (en) * 1996-10-28 2001-11-13 Novo Nordisk A/S cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5958967A (en) 1996-10-28 1999-09-28 Novo Nordisk A/S Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
JP2002503213A (ja) 1996-10-28 2002-01-29 ノボ ノルディスク アクティーゼルスカブ エストロゲン関連疾患または症候群の防止または治療に有用な新規なｃｉｓ―３，４―クロマン誘導体
ZA979650B (en) 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979643B (en) 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
CA2270113A1 (en) * 1996-10-28 1998-05-07 Poul Jacobsen Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979649B (en) 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
US5994390A (en) 1996-10-28 1999-11-30 Novo Nordisk Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129616A0 (en) 1996-10-28 2000-02-29 Novo Nordisk As Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
JP2001502703A (ja) 1996-10-28 2001-02-27 ノボ ノルディスク アクティーゼルスカブ （−）―３，４―トランス―ジアリールクロマンの調製方法
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
ES2191170T3 (es) 1996-10-28 2003-09-01 Novo Nordisk As Nuevos (-)-enantiomeros de derivados de cis-3,4-cromano utiles en la prevencion y tratamiento de sindromes o enfermedades relacionadas con el estrogeno.
JP3251946B2 (ja) * 1996-12-13 2002-01-28 中外製薬株式会社 新規なベンゾピラン誘導体
AU5550298A (en) 1997-01-29 1998-08-25 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor increasing libido in post-menopausal women
ZA98682B (en) 1997-01-29 1998-07-29 Novo Nordisk As Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
ZA98681B (en) 1997-01-29 1998-07-29 Novo Nordisk As Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibition senescense-associated motor impairment
AU3456499A (en) 1998-03-30 1999-10-18 University Of Mississippi, The Isoflavones for treating giardiasis and malaria
EP1073762A1 (de) 1998-04-28 2001-02-07 Novo Nordisk A/S Enzymatische auflosung zur gewinnung von (-)-3,4,-trans-diarylchroman
FR2778404B1 (fr) 1998-05-06 2000-06-30 Hoechst Marion Roussel Inc Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
KR20000001793A (ko) 1998-06-13 2000-01-15 이경하 신규한 벤조피란 또는 티오벤조피란 유도체
AUPP868599A0 (en) 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
AUPQ008299A0 (en) 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
AUPQ266199A0 (en) 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AU7896100A (en) 1999-10-14 2001-04-23 Endorecherche Inc. Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
US6610733B2 (en) 1999-12-13 2003-08-26 Chugai Seiyaku Kabushiki Kaisha Optically active chroman and thiochroman derivatives
NZ534348A (en) 2000-01-28 2006-06-30 Endorech Inc Selective estrogen receptor modulators in combination with estrogens
FI20001593A7 (fi) 2000-07-03 2002-01-04 Orion Yhtymo Oyj Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
ATE286894T1 (de) * 2001-01-24 2005-01-15 Chiesi Farma Spa 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
US6927224B2 (en) 2001-08-11 2005-08-09 Bristol Myers Squibb Company Selective estrogen receptor modulators
AUPR846401A0 (en) 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
EP1465619A1 (de) 2002-01-14 2004-10-13 Nordic Bioscience A/S Bekämpfung des knorpelgewebeabbaus durch wirkung auf das östrogenrezeptor
CN1646119A (zh) 2002-04-09 2005-07-27 诺沃根研究有限公司 涉及异黄－3－烯和异黄烷结构的治疗方法和组合物
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
JP2007525485A (ja) * 2003-11-19 2007-09-06 ノボゲン リサーチ ピーティーワイ リミテッド 複合的な放射線治療及び化学治療の組成物及び方法
AU2005287865B2 (en) 2004-09-21 2012-02-16 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
JP4976649B2 (ja) 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物
WO2006032086A1 (en) 2004-09-21 2006-03-30 Novogen Research Pty Ltd Chroman derivatives, medicaments and use in therapy
US8080675B2 (en) * 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP2120925A4 (de) 2007-03-16 2010-04-07 Novogen Res Pty Ltd Verfahren zur einleitung von autophagie
WO2010022467A1 (en) 2008-08-29 2010-03-04 Novogen Research Pty Ltd Immunomodulating activities
WO2012061413A2 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compositions and methods for the treatment of cancer
US20120251630A1 (en) 2011-03-29 2012-10-04 Marshall Edwards, Inc. Remission therapy of cancer with isoflavonoids

Also Published As

Publication number Publication date
US20150352074A1 (en) 2015-12-10
EP1794141A1 (de) 2007-06-13
CA2581316C (en) 2013-09-10
US8697891B2 (en) 2014-04-15
EP2407462A1 (de) 2012-01-18
US20140170243A1 (en) 2014-06-19
EP2407462B1 (de) 2014-07-30
NZ553834A (en) 2010-03-26
IL182034A0 (en) 2007-07-24
EP1794141B1 (de) 2011-11-09
AU2005287865A1 (en) 2006-03-30
US20060074127A1 (en) 2006-04-06
US9381186B2 (en) 2016-07-05
CN101056868B (zh) 2012-05-02
CA2581316A1 (en) 2006-03-30
US20160287555A1 (en) 2016-10-06
NO20072004L (no) 2007-05-30
EP1794141A4 (de) 2009-05-27
US20090317490A1 (en) 2009-12-24
US20120114766A1 (en) 2012-05-10
US8084628B2 (en) 2011-12-27
WO2006032085A1 (en) 2006-03-30
CN101056868A (zh) 2007-10-17
AU2005287865B2 (en) 2012-02-16
US7601855B2 (en) 2009-10-13
US9138478B2 (en) 2015-09-22
MX2007003216A (es) 2008-03-10
IL182034A (en) 2012-10-31

Similar Documents

Publication Publication Date Title
NO20072004L (no) Substituerte kromanderivater, medikamenter og anvendelse i terapi
ATE365703T1 (de) Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungen
CY1116373T1 (el) Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη
DK1951729T3 (da) Oxygenbundne pyrimidinderivater
DE60318013D1 (de) N-oxid von n-phenyl-2-pyrimidinaminderivaten
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
CY1108592T1 (el) Διϋδροτετραβεναζινες και φαρμακευτικες συνθεσεις που τις περιεχουν
ATE472551T1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
BRPI0410913A (pt) benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
IL163090A (en) Nicotinamide derivates, pharmaceutical compositions comprising them and their use for manufacture of medicaments useful as p38 inhibitors
ECSP067098A (es) Compuestos y metodos para el tratamiento de dislipidemia
DE602006013622D1 (de) Steroids und anwendungen davon
DK1432402T3 (da) Sammensætning til tilförsel af lægemiddelkombinationer
JO2721B1 (en) Derivatives of artemisia plant and its preparations and therapeutic applications
BRPI0511874A (pt) derivados da pirrolopiridina
UY29036A1 (es) Derivados de oxopiperidina, su preparacion y su aplicacion en terapeutica
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
ATE545644T1 (de) Benzimidazolderivate, diese enthaltende zusammensetzungen, herstellung davon und anwendungen davon i
WO2006097617A3 (fr) Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux
WO2004026319A3 (en) Pharmaceutical compositions increasing camp useful for the treatment of cancers
WO2008036067A3 (en) Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
WO2006132947A3 (en) 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof
ATE424196T1 (de) Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen
WO2005097757A3 (en) Nucleoside derivatives and therapeutic use thereof
ATE508750T1 (de) Derivate von vitamin d und ihre verwendung in der therapie